欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号BE/H/0120/001
药品名称Cirrus 5mg/120mg
活性成分
    • Cetirizine dihydrochloride 5.0 mg
    • Pseudoephedrine hydrochloride 120.0 mg
剂型Prolonged-release tablet
上市许可持有人UCB Pharma SA Allée del la recherche 60 1070 Bruxelles Belgium
参考成员国 - 产品名称Belgium (BE)
Cirrus 5mg/120mg comprimés à libération prolongée
互认成员国 - 产品名称
    • Ireland (IE)
    • Cyprus (CY)
      Zyrtec D prolonged release tablets
    • Malta (MT)
      Cirrus prolonged release tablets
许可日期2005/09/15
最近更新日期2024/11/28
药物ATC编码
    • R01BA52 pseudoephedrine, combinations
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Full Dossier [Article 8.3(i)]
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Non Prescription (including OTC)
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase